Dermata Therapeutics earnings were -$8.4M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest DRMA earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$3.0M, up 60.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, DRMA reported annual earnings of -$7.6M, with -38.5% growth. The next DRMA earnings date is Nov 13, 2026.
Dermata Therapeutics Earnings Reports & History FAQ
What were Dermata Therapeutics's earnings last quarter?
On DRMA's earnings call on Aug 12, 2026, Dermata Therapeutics (NASDAQ: DRMA) reported Q2 2026 earnings per share (EPS) of -$0.74, up 55.42% year over year. Total DRMA earnings for the quarter were -$2.97 million. In the same quarter last year, Dermata Therapeutics's earnings per share (EPS) was -$1.66.
The next DRMA earnings date is Nov 13, 2026. Add DRMA to your watchlist to be reminded of Dermata Therapeutics's next earnings date.
What was DRMA's earnings growth in the past year?
As of Dermata Therapeutics's earnings date in Aug 12, 2026, Dermata Therapeutics's earnings has grown year over year. DRMA earnings in the past year totalled -$8.37 million.
Is Dermata Therapeutics profitable or losing money?
As of the last Dermata Therapeutics earnings report, Dermata Therapeutics is currently losing money. Dermata Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$8.37 million, a 18.98% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.